Clinical Trial Imaging Industry Overview The global clinical trial imaging market is expected to reach USD 1.97 billion by 2030, exhibiting a CAGR of 8.7%, according to a new report by Grand View Research, Inc. Increasing research and development spending to discover new drugs and therapies to treat chronic diseases is propelling the industry growth. Images obtained from the internal examination of the body are used to determine drug activity. Clinical trial imaging provides rapid, detailed, and accurate screening. The need for clinical trial imaging is rapidly increasing in all phases of trials. Medical imaging in clinical trials is used as a primary, quantitative, and surrogate biomarker. Clinical Trial Imaging Market Segmentation Grand View Research has segmented the global clinical trial imaging market on the basis of service, application, end-use, and region: Based on the Service Insights, the market is segmented into clinical trial design and consultation services, reading and analytical services, operational imaging services, system and technology support services and project and data management
Based on the Application Insights, the market is segmented into NASH, CKD, diabetes, cardiovascular diseases and others
Based on the End-use Insights, the market is segmented into biotechnology and pharmaceutical companies, medical devices manufacturers, academic and government research institutes, CROs and others
Clinical Trial Imaging Regional Outlook
Key Companies Profile & Market Share Insights Some of the key players in this market are Parexel International Corporation, Intrinsic Imaging, Bioclinica, and ICON plc. These market players are focusing on growth strategies such as mergers & acquisitions as well as signing contracts. Some of the prominent players in the global clinical trial imaging market include:
Market Industry Development
Order a free sample PDF of the Clinical Trial Imaging Market Intelligence Study, published by Grand View Research. About Grand View Research Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc. Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email: [email protected] Web: https://www.grandviewresearch.com Follow Us: LinkedIn | Twitter
0 Comments
Leave a Reply. |
Archives
December 2023
Categories |